Cambridge, UK., 21 September 2020: Arecor Limited (“Arecor” or “the Company”), the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces that its abstract titled ‘Phase I study investigating the PD, PK and safety of AT247 in comparison to insulin aspart, NovoRapid®, and fast insulin aspart, Fiasp®, has been selected for oral presentation at the upcoming European Association for the Study of Diabetes (EASD) virtual meeting which will be held from 21-25 September 2020. Abstract #55 is available online.
Dr Eva Svehlikova, Medical Director of the…
Growth continues at Discovery Park as new tenants arrive
Psyros Diagnostics & VisusNano join innovation community
Sandwich, Kent, September 21 2020 – The innovation community is continuing to evolve at Discovery Park, the Life Sciences Opportunity Zone for ambitious and growing life sciences companies, as new tenants move in and others continue to develop. New entrants Psyros Diagnostics and VisusNano have both taken laboratory and office space at the Park.
Medtech company VisusNano’s new facilities will enable the rapid scale up of the company’s proprietary biodegradable intraocular…
StemFit® for Mesenchymal Stem Cells (MSC) is the latest addition to the StemFit® family of stem cell media. It is a chemically defined and human/animal origin free medium, optimized for the isolation and culture of MSCs from bone marrow (BM-MSC), umbilical cord (UC-MSC), and adipose (ADSC) under serum-free, human platelet lysate free conditions.The fully chemically defined formulation of StemFit® for MSC minimizes lot-to-lot variation and enables highly consistent and superior cell expansion compared to serum containing media. Containing no animal or human-derived components minimizes…
Pharmaceutical and biotech product development consultancy Boyds has recruited Kathryn Bartley as Senior Clinical Research Associate.
The appointment follows last year’s acquisition of Blue Duck Consultancy which fueled the expansion of Boyds’ in-house clinical and medical affairs services offering.
Kathryn has over 18 years’ experience in the industry, primarily in study and site management and monitoring. Her work has covered a variety of therapy areas across all trial phases within both the commercial and academic sectors.
Most recently, Kathryn spent six years working for GlaxoSmithKline…
Cambridge, UK, 08 September 2020: Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, today announced it has significantly enhanced its global business development capabilities, with additional resources now committed to support key regions in the USA, Europe and Japan.
Anca Haralambie has been appointed as Business Development Executive, representing Metrion in the UK and across Europe. Anca has broad experience of supporting clients in the global drug discovery sector, with particular expertise in translational research and induced…
9 September 2020, Oxfordshire, UK/Boston, US – Life Science Newswire – Precision medicine company PrecisionLife has appointed Simon Beaulah as SVP of Healthcare and Head of US Operations. Simon’s appointment demonstrates the company’s focus on developing the US market and its commercial profile within the healthcare and precision medicine fields. Simon brings with him a wealth of experience, having spent more than 20 years leading product and business strategy and teams for innovative informatics businesses in the healthcare and life science ecosystems.Most recently, Simon was Director of…
Cambridge, UK, and Cambridge, MA, 08 September 2020: PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, and XtalPi Inc., a leading algorithm-driven artificial intelligence (AI)-based pharmaceutical technology company, today announced they have entered into a drug discovery collaboration agreement. Financial details are not disclosed.
Under the terms of agreement, PhoreMost and XtalPi will rapidly identify and develop compounds to advance a drug discovery program against targets that epigenetically regulate tumour progression, and…
CAMBRIDGE, UK 09 September 2020 – EVONETIX LTD (‘Evonetix’), the synthetic biology company developing a desktop platform for scalable, high-fidelity and rapid gene synthesis, today announced a collaboration with leading, global high-performance analog technology company, Analog Devices, Inc. The companies will work together on the advancement and commercial scale-up of Evonetix’s proprietary microelectromechanical systems (MEMS)-based silicon chips and accelerate the development of Evonetix’s first product, a DNA desktop writer.
Evonetix’s novel silicon chip controls the…
TTP will provide entrepreneurs with mentoring and tech consultancy, to accelerate product development and commercialisation
Agreement underlines TTP’s commitment to sharing knowledge and experience with innovative start-ups
TTP to deliver virtual seminar on 17 September as part of Start Codon and Cancer Research UK’s Entrepreneurial Training Scheme
Cambridge, UK, 03 September 2020: TTP plc (TTP), a leading independent technology and product development company, has today announced a new partnership with Start Codon, the life science and healthcare business accelerator. The collaboration…
Executive search consultancy, Horton International UK, has announced the appointment of Mark Johnson as Senior Partner of its Oxford-based Global Healthcare arm.
With a background in manufacturing/quality and development for the vaccine industry, Mark’s expertise has informed his career in executive search for the pharmaceutical, life sciences and healthcare industries, from board level to middle management. Most recently a Partner with a global Life Sciences recruitment business, Mark has spent years focused upon building high-performance leadership and technical teams for fast growing…